AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Pertuzumab in Zambia
1 product registered with ZAMRA β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Pertjeta Solution for influsion | ZAMRA-HM-25-159 | Roche Products | active | 8 May 2030 |
Pertuzumab β ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Pertuzumab, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Pertuzumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.